ADAR1 Capital Management »

Prime Medicine shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.9M 2.0M 3.48

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Prime Medicine

Alphabet
BlackRock
Vanguard Group
ARK Investment Management
T. Rowe Price Investment Management
State Street Corporation
Vanguard Capital Management
Balyasny Asset Management
Casdin Capital
Woodline Partners
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Geode Capital Management
FMR

View all funds holding Prime Medicine